PANTR1 and cancer: Finally, additional biomarkers, such as CD33 for acute myeloid leukemia (iGEM BIOTEC Dresden, 2010), volatile organic compounds (xylene, ethanol, formaldehyde, cyclohexane) for lung cancer diagnosis (iGEM SMTexas, 2014; iGEM Bilkent-UNAMBG, 2016; iGEM Chalmers-Gothenburg, 2017), IL-8 (iGEM CGU Taiwan, 2015), glypican 1 (iGEM Stony Brook, 2016), β-catechin (iGEM ASIJ Tokyo, 2017), and PANTR1 (iGEM Evry_Paris-Saclay, 2022) have been employed for detecting various other cancers.